Evidence map›Paper›PMID 31240317›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2020

Corticosteroids and Regional Variations in Thickness of the Human Cerebral Cortex across the Lifespan.

Nadine Parker, Didac Vidal-Pineiro, Leon French, Jean Shin, Hieab H H Adams, Henry Brodaty, Simon R Cox, Ian J Deary, Anders M Fjell, Stefan Frenzel and 22 more

Open access · hybridAbstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 19 institutions in 10 countries.

Nadine ParkerInstitute of Medical Science, University of Toronto, Toronto M5S 1A8, Canada.
Didac Vidal-PineiroCentre for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Oslo 0373, Norway.
Leon FrenchCentre for Addiction and Mental Health, University of Toronto, Toronto M5T 1L8, Canada.
Jean ShinThe Hospital for Sick Children, University of Toronto, Toronto M5G 0A4, Canada.
Hieab H H AdamsDepartment of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam 3015, the Netherlands.
Henry BrodatyCentre for Healthy Brain Ageing and Dementia Centre for Research Collaboration, University of New South Wales, Sydney, NSW 2025, Australia.
Simon R CoxCentre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh EH8 9JZ, UK.
Ian J DearyCentre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh EH8 9JZ, UK.
Anders M FjellCentre for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Oslo 0373, Norway.
Stefan FrenzelDepartment of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald 17489, Germany.
Hans GrabeDepartment of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald 17489, Germany.
Norbert HostenInstitute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald 17489, Germany.
Mohammad Arfan IkramDepartment of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam 3015, the Netherlands.
Jiyang JiangCentre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, NSW 2052, Australia.
Maria J KnolDepartment of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam 3015, the Netherlands.
Bernard MazoyerGroupe d'Imagerie Neurofonctionnelle, Institut des Maladies Neurodégénératives, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique, et Université de Bordeaux, Bordeaux 5293, France.
Aniket MishraBordeaux Population Health Research Center, INSERM UMR, University of Bordeaux, Bordeaux 33076, France.
Perminder S SachdevCentre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, NSW 2052, Australia.
Giovanni SalumDepartment of Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre 90040-060, Brazil.
Claudia L SatizabalGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, UT Health San Antonio, TX 78229, USA.
Helena SchmidtGottfried Schatz Research Center for Cell Signaling, Metabolism and Aging, Medical University of Graz 8036, Austria.
Reinhold SchmidtClinical Division of Neurogeriatrics, Department of Neurology, Medical University of Graz 8036, Austria.
Sudha SeshadriGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, UT Health San Antonio, TX 78229, USA.
Gunter SchumannMRC-Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London SE5 8AF, UK.
Henry VölzkeDepartment of SHIP/Clinical-Epidemiological Research, Institute for Community Medicine, University Medicine Greifswald, Greifswald 17489, Germany.
Kristine B WalhovdCentre for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Oslo 0373, Norway.
Wei WenCentre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, NSW 2052, Australia.
Katharina WittfeldDepartment of Psychology, University of Edinburgh, Edinburg EH8 9JZ, UK.
Qiong YangDepartment of Biostatistics, Boston University School of Public Health, MA 02118, USA.
Stephanie DebetteBordeaux Population Health Research Center, INSERM UMR, University of Bordeaux, Bordeaux 33076, France.
Zdenka PausovaThe Hospital for Sick Children, University of Toronto, Toronto M5G 0A4, Canada.
Tomáš PausInstitute of Medical Science, University of Toronto, Toronto M5S 1A8, Canada.
Erasmus MC · NLUniversitätsmedizin Greifswald · DEUniversity of Edinburgh · GBUniversity of Toronto · CAUNSW Sydney · AUBoston University · USMedical University of Graz · ATOslo University Hospital · NOGerman Center for Neurodegenerative Diseases · DEHolland Bloorview Kids Rehabilitation Hospital · CAHospital for Sick Children · CAInserm · FRInstitut des Maladies Neurodégénératives · FRKing's College London · GBPrince of Wales Hospital · AUThe University of Texas Health Science Center at San Antonio · USUniversidade Federal do Rio Grande do Sul · BRUniversité de Bordeaux · FRUniversity of Oslo · NO

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI FAGAN, ANNE · 1985 to 2019
$52.1M
The natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 2005 to 2025
$49.5M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Mapping the Human Connectome: Structure, Function, and HeritabilityU54MH091657 · NIMH · WASHINGTON UNIVERSITY · PI UGURBIL, KAMIL, VAN ESSEN, DAVID C · 2010 to 2014
$34.7M
Research Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI DAVID M. HOLTZMAN · 2020 to 2026
$28.7M
South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Mohamad Habes · 2021 to 2026
$24.0M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimer's Disease in the Framingham CohortsR01AG054076 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI DECARLI, CHARLES, SESHADRI, SUDHA · 2016 to 2020
$12.3M
THE XNAT IMAGING INFORMATICS PLATFORMR01EB009352 · NIBIB · WASHINGTON UNIVERSITY · PI Daniel Scott Marcus · 2009 to 2026
$9.3M
Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC)RF1AG059421 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SESHADRI, SUDHA · 2018 to 2018
$6.1M
Medical Research Council G0701120Medical Research Council G1001245Medical Research Council MR/M013111/1Medical Research Council MR/N027558/1Medical Research Council MR/R024065/1NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG026276NIA NIH HHS P30 AG066444NIA NIH HHS P30 AG066546NIA NIH HHS P50 AG005681NIA NIH HHS R01 AG043434NIA NIH HHS R01 AG054076NIA NIH HHS RF1 AG059421NIA NIH HHS U01 AG052409NIBIB NIH HHS R01 EB009352NIMH NIH HHS U54 MH091657NINDS NIH HHS R01 NS017950
6 · The paper itself

Abstract

Exposures to life stressors accumulate across the lifespan, with possible impact on brain health. Little is known, however, about the mechanisms mediating age-related changes in brain structure. We use a lifespan sample of participants (n = 21 251; 4-97 years) to investigate the relationship between the thickness of cerebral cortex and the expression of the glucocorticoid- and the mineralocorticoid-receptor genes (NR3C1 and NR3C2, respectively), obtained from the Allen Human Brain Atlas. In all participants, cortical thickness correlated negatively with the expression of both NR3C1 and NR3C2 across 34 cortical regions. The magnitude of this correlation varied across the lifespan. From childhood through early adulthood, the profile similarity (between NR3C1/NR3C2 expression and thickness) increased with age. Conversely, both profile similarities decreased with age in late life. These variations do not reflect age-related changes in NR3C1 and NR3C2 expression, as observed in 5 databases of gene expression in the human cerebral cortex (502 donors). Based on the co-expression of NR3C1 (and NR3C2) with genes specific to neural cell types, we determine the potential involvement of microglia, astrocytes, and CA1 pyramidal cells in mediating the relationship between corticosteroid exposure and cortical thickness. Therefore, corticosteroids may influence brain structure to a variable degree throughout life.

Indexed as

AdolescentAdultAgedAged, 80 and overAgingCerebral CortexChildChild, PreschoolFemaleGene ExpressionHumansMaleMiddle AgedReceptors, GlucocorticoidReceptors, MineralocorticoidYoung AdultNR3C1 protein, humanNR3C2 protein, humanReceptors, GlucocorticoidReceptors, Mineralocorticoid

Identifiers

PMID31240317
PMCPMC7444740
OpenAlexW2955551213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.